SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
23.00
-0.65 (-2.75%)
Apr 28, 2026, 4:00 PM EDT - Market closed
SpyGlass Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Market Capitalization | 762 | - | - |
| Enterprise Value | 663 | - | - |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.32 |
| Net Debt / Equity Ratio | -1.00 | -1.00 | -1.02 |
| Net Debt / EBITDA Ratio | 2.59 | 2.59 | 0.46 |
| Net Debt / FCF Ratio | 3.16 | 3.16 | 0.52 |
| Quick Ratio | 12.57 | 12.57 | 2.14 |
| Current Ratio | 12.67 | 12.67 | 2.23 |
| Return on Equity (ROE) | -67.70% | -67.70% | - |
| Return on Assets (ROA) | -37.23% | -37.23% | - |
| Return on Capital Employed (ROCE) | -38.60% | -38.60% | -174.30% |
| Buyback Yield / Dilution | - | -23.98% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.